Cristina R. Alexandru
Rouen, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
The clinical impact of EGFR alterations in elderly glioblastoma patients: results from a real-life cohort.
Journal: Journal of neuro-oncology
Published: October 03, 2024
Metabolic remodeling in glioblastoma: a longitudinal multi-omics study.
Journal: Acta neuropathologica communications
Published: July 07, 2024
Prognostic value of circulating short-length DNA fragments in unresected glioblastoma patients.
Journal: Translational oncology
Published: November 09, 2023
Impact of EGFRA289T/V mutation on relapse pattern in glioblastoma.
Journal: ESMO open
Published: September 12, 2022
Usefulness of circulating tumor DNA from cerebrospinal fluid in recurrent high-grade glioma.
Journal: Revue neurologique
Published: August 02, 2021
Mfge8 attenuates human gastric antrum smooth muscle contractions.
Journal: Journal of muscle research and cell motility
Published: March 28, 2021
Analyzing the Integrin Adhesome by In Situ Proximity Ligation Assay.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: November 20, 2020
Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma.
Journal: Acta neuropathologica communications
Published: August 26, 2020
Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma.
Journal: Acta neuropathologica communications
Published: January 29, 2020
Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer.
Journal: Breast cancer research : BCR
Published: January 14, 2020
Randomised phase II trial evaluating the safety of peripherally inserted catheters versus implanted port catheters during adjuvant chemotherapy in patients with early breast cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 11, 2019
Deleterious impact of a generic temozolomide formulation compared with brand-name product on the kinetic of platelet concentration and survival in newly diagnosed glioblastoma.
Journal: Fundamental & clinical pharmacology
Published: June 23, 2019
Last Updated: 09/26/2026